Derm-Biome Plans to Advance Topical AK Therapy Following Positive Preclinical Trial
Derm-Biome’s investigational topical therapy may prevent the development of actinic keratoses and halt the progression of skin cancers, according to preclinical work. In a recent UV-induced skin cancer trial, mice were exposed to UVB radiation over a period of 25 weeks. Topical application of Derm-Biome’s compound prior to UVB exposure significantly reduced the number and size of precancerous lesions, while treatment blocked the progression of squamous cell […]